Drug points

British Medical Journal

Volumn 320, Issue 7244, 2000, Pages 1245-

  Hettiaratchy, Shehan ^a   Clarke, John ^a   Taubel, Jorg ^b   Besa, Chola ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b Charterhouse Clinical Research Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN; PHOTOSENSITIZING AGENT; TEMOPORFIN;

ADULT; ARTICLE; BURN; CLINICAL TRIAL; DRUG HALF LIFE; DRUG SELECTIVITY; FOREARM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; SCAR FORMATION; SUNLIGHT; THICKNESS; WOUND DRESSING; WOUND HEALING;

EID: 20244382814     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. 1 Kublet AC, Haase T, Staff C, Kahle B, Rheinwald M, Muhling J. Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck. Lasers Surg Med 1999;25:60-8.
2. 2 McCaughan JS Jr, Williams TE. Photodynamic therapy for endobronchial malignant disease: a prospective fourteen-year study. J Thorac Cardiovasc Surg 1997;114:940-6.
3. 3 Dilkes MG, De Jode ML, Gardiner Q, Kenyon GS, McKelvie P. Treatment of head and neck cancer with photodynamic therapy: results after one year. J Laryngol Otol 1995;109:1072-6.
4. 4 Farber NE, McNeely J, Rosner D. Skin burn associated with pulse oximetry during perioperative photodynamic therapy. Anesthesiology 1996;84:983-5.